Cognetivity Neurosciences Ltd. Stock
Stocks
CGNSF
CA19243C1005
Advanced Medical Equipment & Technology
OTC Markets Traded|
Real-time
OTC Markets
21:30:34 18/03/2025 HKT
|
5-day change | 1st Jan Change | ||
| 0.001900 USD | -17.39% |
|
+189,900.00% | +189,900.00% |
| 1 week | +189,900.00% | ||
| Current month | +189,900.00% |
| Market Cap | 1.2M 867K 743K 695K 635K 82.97M 1.21M 8.22M 3.2M 41.66M 3.25M 3.18M 138M | P/E 2022 |
-2.9x | P/E 2023 | -2.8x |
|---|---|---|---|---|---|
| Enterprise Value | 245K 177K 152K 142K 130K 16.97M 248K 1.68M 654K 8.52M 666K 651K 28.2M | EV / Sales 2022 |
-
| EV / Sales 2023 | 437,922,999x |
| Free-Float |
85.56% | Yield 2022 * |
-
| Yield 2023 | - |
| 1 day | -17.39% | ||
| 1 week | +189,900.00% | ||
| Current month | +189,900.00% | ||
| 1 month | +189,900.00% | ||
| 3 months | +189,900.00% | ||
| 6 months | +189,900.00% | ||
| Current year | +189,900.00% |
| Current year | 0 |  | 0 |
| 1 year | 0 | | 0 |
| 3 years | 0 | | 0.14 |
| 5 years | 0 | | 0.7 |
| 10 years | 0 | | 1.12 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sina Habibi
CEO | Chief Executive Officer | 45 | 01/04/2013 |
Mark Phillips
CMP | Compliance Officer | 67 | 21/12/2017 |
| Director | Title | Age | Since |
|---|---|---|---|
Sina Habibi
BRD | Director/Board Member | 45 | 01/01/2017 |
Mark Phillips
BRD | Director/Board Member | 67 | 21/12/2017 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 15/4/24 | Option | Founder | 600,000 | 0.6697% | ||
| 15/4/24 | Option | Founder | 600,000 | 0.6697% | ||
| 23/6/23 | Sell | Founder | 1,108,160 | 1.3030% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -17.39% | +189,900.00% | +1,800.00% | -98.39% | 93 | |
| +0.31% | +4.33% | -12.80% | +33.41% | 40.27B | |
| +0.96% | +8.15% | -36.87% | +168.43% | 14.35B | |
| -0.79% | -1.50% | -20.75% | +63.10% | 5.66B | |
| +0.41% | +19.10% | +67.39% | - | 4.33B | |
| +11.17% | +13.00% | - | - | 2.07B | |
| -2.54% | -4.25% | +4.26% | -38.36% | 1.62B | |
| -4.24% | +16.97% | -32.54% | - | 1.18B | |
| -0.29% | +10.20% | +48.29% | +153.18% | 1.03B | |
| -0.66% | -2.69% | +48.50% | +62.15% | 1.03B | |
| Average | -1.40% | +5.35% | +207.28% | +49.07% | 7.15B | |
| Weighted average by Cap. | +0.45% | +3.80% | -11.55% | +66.90% |
| 2022 | 2023 | |
|---|---|---|
| Net sales | - | 0.05 0.03 0.03 0.03 0.02 3.14 0.05 0.31 0.12 1.58 0.12 0.12 5.22 |
| Net income | -13.13M -9.49M -8.13M -7.61M -6.96M -909M -13.27M -90.04M -35.01M -456M -35.63M -34.86M -1.51B | -7.43M -5.37M -4.61M -4.31M -3.94M -515M -7.51M -50.99M -19.83M -258M -20.18M -19.74M -855M |
| Net Debt | -82.43K -59.59K -51.07K -47.78K -43.68K -5.71M -83.31K -565K -220K -2.87M -224K -219K -9.48M | -953K -689K -591K -553K -505K -66M -964K -6.54M -2.54M -33.14M -2.59M -2.53M -110M |
Employees
-
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CGNSF Stock
Select your edition
All financial news and data tailored to specific country editions
